Inhibition of Matrix Metalloproteinases by Mapracorat, a Novel Selective Glucocorticoid Receptor Agonist (SEGRA), in Human Corneal Epithelial Cells

被引：0
|
作者：
Vollmer, Thomas [1 ]
Harrington, Karen [1 ]
Zhang, Jin-Zhong [1 ]
Richardson, Mary [1 ]
Cavet, Megan [1 ]
机构：
[1] Bausch Lomb, Preclin Pharmacol, Rochester, NY USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2013年 / 54卷 / 15期
关键词：
480 cornea: basic science; 557; inflammation; 675 receptors: pharmacology/physiology;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
6029
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells
    Cavet, Megan E.
    Harrington, Karen L.
    Ward, Keith W.
    Zhang, Jin-Zhong
    MOLECULAR VISION, 2010, 16 (194-95): : 1791 - 1800
  • [2] Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells
    Cavet, Megan E.
    Volhejn, Stepan
    Harrington, Karen L.
    Zhang, Jin-Zhong
    MOLECULAR VISION, 2013, 19 : 1515 - 1525
  • [3] Induction of MAPK Phosphatase-1 by the Novel Selective Glucocorticoid Receptor Agonist Mapracorat Supprees Inflammatory Signaling Pathways in Human Corneal Epithelial Cells
    Cavet, Megan
    Harrington, Karen
    Vollmer, Thomas
    Richardson, Mary
    Zhang, Jin-Zhong
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [4] Ocular Pharmacokinetics of Mapracorat, a Novel, Selective Glucocorticoid Receptor Agonist, in Rabbits and Monkeys
    Proksch, Joel W.
    Lowe, Ezra R.
    Ward, Keith W.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (07) : 1181 - 1187
  • [5] ZK 245186, a novel, selective glucocorticoid receptor agonist (SEGRA) for the topical therapy of inflammatory skin diseases
    Schaecke, H.
    Zollner, T. M.
    Doecke, W.
    Rehwinkel, H.
    Jaroch, S.
    Skuballa, W.
    Neuhaus, R.
    May, E.
    Zuegel, U.
    Asadullah, K.
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (03) : 305 - 305
  • [6] Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist
    Baiula, Monica
    Sparta, Antonino
    Bedini, Andrea
    Carbonari, Gioia
    Bucolo, Claudio
    Ward, Keith W.
    Zhang, Jin-Zhong
    Govoni, Paolo
    Spampinato, Santi
    MOLECULAR VISION, 2011, 17 (346-48): : 3208 - 3223
  • [7] BOL-303242-X, a Novel Selective Glucocorticoid Receptor Agonist, Inhibits Hyperosmolarity-Induced Cytokine Release in Human Corneal Epithelial Cells
    Zhang, J. -Z.
    Cavet, M. E.
    Harrington, K. L.
    VanDerMeid, K. R.
    Lopez, F. J.
    Ward, K. W.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [8] In Vivo Ocular Efficacy Profile of Mapracorat, a Novel Selective Glucocorticoid Receptor Agonist, in Rabbit Models of Ocular Disease
    Shafiee, Afshin
    Bucolo, Claudio
    Budzynski, Ewa
    Ward, Keith W.
    Lopez, Francisco J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (03) : 1422 - 1430
  • [9] Effect of the Topical Selective Glucocorticoid Receptor Agonist, Mapracorat, in Experimental Dry Eye Disease
    Eiglmeier, Susanne
    Sadrai, Zahra
    Chen, Yihe
    Chauhan, Sunil K.
    Dana, Reza
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [10] Identification of the selective glucocorticoid receptor agonist Mapracorat as potential new drug for chronic wound therapy
    Wolff-Winiski, B.
    Schoefmann, N.
    Doerfler, P.
    Cabral, G.
    Stuetz, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S286 - S286
12345